Innoveren Scientific, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Innoveren Scientific, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q3 2023.
  • Innoveren Scientific, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$74.5K, a 82.4% increase year-over-year.
  • Innoveren Scientific, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$377K, a 93.1% increase year-over-year.
  • Innoveren Scientific, Inc. annual Nonoperating Income (Expense) for 2022 was -$5.19M, a 1168% decline from 2021.
  • Innoveren Scientific, Inc. annual Nonoperating Income (Expense) for 2021 was $486K, a 23.2% decline from 2020.
  • Innoveren Scientific, Inc. annual Nonoperating Income (Expense) for 2020 was $633K, a 15.6% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$377K -$74.5K +$349K +82.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-15
Q2 2023 -$726K $1.23M +$3.04M Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-15
Q1 2023 -$3.76M -$1.67M +$1.43M +46.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 -$5.19M $138K +$236K Oct 1, 2022 Dec 31, 2022 10-K 2023-05-10
Q3 2022 -$5.43M -$424K -$1.06M -166% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 -$4.37M -$1.81M -$1.75M -3381% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-15
Q1 2022 -$2.61M -$3.1M -$3.1M -68733% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $486K -$98K -$32.1K -48.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-05-10
Q3 2021 $518K $641K -$4.25M -86.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $4.77M -$51.9K +$4.46M +98.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $314K -$4.51K -$320K -101% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $633K -$65.9K -$183K -156% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 $816K $4.89M +$4.09M +509% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$3.27M -$4.51M -$4.43M -5689% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $1.16M $315K +$407K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $751K $117K +$256K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $495K $803K +$854K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$359K -$77.9K -$35.7K -84.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$323K -$92.5K -$121K -422% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-21
Q4 2018 -$202K -$138K +$648K +82.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-22
Q3 2018 -$850K -$50.3K -$48.6K -2940% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$801K -$42.2K -$43.7K -3036% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$757K $28.7K -$362K -92.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$395K -$786K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-10
Q3 2017 -$1.65K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.44K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $391K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.